International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors.
1/5 보강
Thymic epithelial tumors are rare diseases, with frequently indolent nature.
APA
Fang W, Detterbeck F, et al. (2026). International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 21(1), 102-111. https://doi.org/10.1016/j.jtho.2025.09.1757
MLA
Fang W, et al.. "International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors.." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 21, no. 1, 2026, pp. 102-111.
PMID
41016430 ↗
Abstract 한글 요약
Thymic epithelial tumors are rare diseases, with frequently indolent nature. A common language is essential for accurate communication in clinical management and research for this disease. The International Thymic Malignancy Interest Group updates its original set of standards for reporting outcome measures of clinical studies to facilitate comparison of results between studies and to promote collaborative research of the disease. These standards include international classification of tumor stage, long-term outcome measures with follow-up policy, standard definitions of recurrence and progression, and reporting measures for surgery and multimodality therapy. Implementing these renewed standards will support more accurate study designs, result reporting, and cross-specialty discussions and will facilitate multi-institutional and global collaboration.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis.
- Death receptor 3: A paradoxical biomarker and therapeutic target in pan-cancer.
- Wnt signaling pathway: Therapeutic target of natural products for cancer therapy.
- Multicomponent Ganoderma lucidum spore-based solid self-nanoemulsifying system of paclitaxel for improved lymphatic absorption and immune synergistic antitumor strategy.
- Sacituzumab Tirumotecan in EGFR-TKI-Resistant, -Mutated Advanced NSCLC.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.